SynBioBeta Speaker
Ekaterine Kortkhonjia
Sr. Director, Partnering
Johnson & Johnson
YEAR
25
May 2025, SynBioBeta
Speaker
Eka is a Senior Director of Early Innovation Partnering at Johnson and Johnson. In this role Eka is responsible for identification, diligence and strategic transactions for data science opportunities across therapeutic areas from discovery through commercial execution. Eka joined Johnson and Johnson from Genentech/Roche where she spent over 10 years in various roles, including Pharma Partnering, Biomarker Development and Finance. Eka hold a Ph. D. in Chemistry and Chemical Biology and M. S. in Biophysics.
SynBioBeta 2025 - Keynote
Innovation Meets Industry: How Startups Can Collaborate with Big Pharma
For startups in the BioPharma space, partnering with big pharma can be the key to scaling innovation and driving real-world impact. This session will bring together leaders from major pharmaceutical companies and successful startups to explore how to bridge the gap between groundbreaking ideas and industry execution. Learn about the key factors pharma companies look for in potential partners, best practices for collaboration" with "Innovation Meets Industry: How Startups Can Collaborate with Big Pharma"
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Previous Speakers Include
2026
Event Updates